The Medical Affairs MSc course will give you the skills to operate as a bridge between the pharmaceutical industry and the wider medical community, including key thought leaders across a range of therapeutic specialisms, as well as with patient groups, regulatory authorities and beyond. The course builds from a sound appreciation of the clinical development of new medicines, to focus on understanding how to effectively link science and commercial activity, by providing scientific and commercial support for medicines. It is designed for scientists, physicians, pharmacists and allied health professionals. This is the world’s first MSc in Medical Affairs and still the only one on offer. This course is delivered in close partnership with the pharmaceutical industry. Many experts from pharma teach, run workshops, supervise dissertations and examine students. Pharma also employs most of our graduates.

Key benefits

• King's is ranked 20th in the world for Pharmacy and Pharmacology (QS World University Rankings by subject 2023)
• Lectures and workshops are delivered by a mixture of academics and expert practitioners from the pharmaceutical industry.
• The course shares several common required modules with both the MSc in Clinical Pharmacology and the MSc in Drug Development Science, thus facilitating transfer between these courses.
• Direct practical experience of medical affairs through a one-week placement in industry.
• Accredited by PharmaTrain as a Centre of Excellence for the provision of state-of-the-art education and training in medicines development, which allows international transfer of credits
• A vibrant cohort of participants, studying both full-time and part-time.
• Modules are taught face to face with half of the time spent in workshops.

Application closing date guidance